The Setup

nLIGHT filed its 10-K on Feb 27. The defense laser weapons thesis is confirmed by primary source data. Every number points the same direction. The problem is the stock already went up 660%.

What the 10-K Shows

A&D revenue: 44% of total (2023) → 55% (2024) → 67% (2025). That's $175.3M, up 60% YoY. This isn't a quarter — it's a three-year structural acceleration driven by "increased unit sales of directed energy laser products." The filing says it explicitly.

Gross margin doubled in one year. Total: 16.6% → 29.8%. Laser Products segment: 22.8% → 39.2%. That's approaching defense contractor margins. Drivers: defense mix shift (higher ASP), volume absorption of fixed costs, duty reclamation, and a shift from cost-plus to fixed-price contracts in Advanced Development.

OCF turned positive: +$21.3M vs -$2.4M prior year. Company drew $20M on its LOC but has $133.9M total liquid ($99M cash + $34.9M Treasuries). No covenant violations. Clean KPMG audit. No going concern.

The USG direct revenue number is the headline: 36% of total, up from 19%. But that UNDERSTATES the true government relationship — the company explicitly discloses classified contracts that "limit investor insight into portions of our business." The $184.4M in unfunded government backlog is new this filing.

Industrial revenue collapsed 45% over two years ($71M → $38.8M). Chinese fiber laser competition (Raycus, IPG) is structural. Company exited ALL China manufacturing in Q4 2024. This is deliberate — ITAR compliance for defense customers matters more than commodity welding revenue.

Still losing money: -$23.5M net. SBC is $33.4M/yr with $82.7M unrecognized. Share count growing ≈2M/year. Path to profitability requires ≈$350M revenue at current margins. Currently at $261M — roughly $90M gap.

What the 8-Ks Add

Three items the 10-K backward-looking view misses:

1. $166.5M equity offering at $44/share (Feb 3, 2026). 3.98M shares = 8% dilution. 60-day insider lock-up expires ~April 6. Post-offering cash >$250M. This creates an institutional floor at $44 — funds who bought the offering won't let that level break easily. Stock at $63 means offering buyers are up 43% in one month.

2. Board hire: Gerald Haines, ex-Mercury Systems CFO (Jan 6). Mercury = defense electronics acquisition platform. Haines led "substantial revenue growth, operational scaling, strategic acquisitions in A&D." Also has Cornell Law JD. Appointed to Audit Committee. Signal: board composition fully aligned with defense pivot. Mercury Systems experience = potential M&A preparation.

3. CEO sold $2.38M open market Jan 6 — the DAY AFTER Haines appointment, one WEEK before the preliminary Q4 beat announcement (Jan 13), and one MONTH before the equity offering (Feb 3). Not 10b5-1 in visible data. Timing is efficient.

Cross-Ticker Corroboration

Searched 5,008 earnings transcripts for directed energy mentions. Seven companies confirmed the DE weapons ramp in Q4 2025 calls: Lockheed Martin, Huntington Ingalls, Leonardo DRS, AeroVironment, Curtiss-Wright, nLIGHT itself, and EOS (Australia). EOS signed the first 100kW laser weapon export contract (EUR 71M, Netherlands) and said there's "only one other competitor globally" — likely Lockheed.

IPG Photonics is pivoting to defense from the SAME industrial decline. Their Crossbow anti-drone laser, new Huntsville factory, and VP of defense hire confirm the sector trend. But IPG is behind — LASR already has 67% defense revenue, IPG is just starting.

The defense laser weapons inflection is REAL and CORROBORATED. It's also a KNOWN SECTOR STORY. Seven companies talking about it on earnings calls = consensus, not discovery.

The Misclassification Anomaly

Factor regression (SPY + MTUM + ITA + IPGP + XLK, 1Y, 250 obs):

Idiosyncratic    70.3%    Company-specific (defense transition)
XLK (Tech)       24.9%    Market STILL classifies LASR as tech
ITA (Defense)     6.4%    Surprisingly LOW given 67% A&D revenue
IPGP (Laser)      4.2%    Decoupling from industrial peer
MTUM (Momentum)   4.8%    +660% 1Y = momentum loading
SPY (Market)    -10.6%    Negative beta — counter-cyclical

XLK explains 25% of variance while ITA explains only 6.4% — on a company that's 67% defense revenue. The market's factor model is WRONG about what LASR is. The stock still trades like a tech company.

This would be alpha if you discovered it 12-18 months ago. The gap was large enough to exploit — it was, and someone made +660%. But 7 analysts are now covering (6 buy, 1 hold, mean PT $69.92). The misclassification is being corrected. By the time ITA loading converges to 20-30% (index reconstitution, analyst re-coverage), the remaining alpha from reclassification is probably 10-20% — which at 13.4x P/S might not justify the premium already paid.

Forward Alpha

Current: $63 | Market cap: $3.5B | P/S: 13.4x | P/GP: 44.9x | FWD P/E: 125x

Bull (40%): $350M rev, 35% GM, breakeven → 10x P/S = $3.5B (FLAT)
Base (40%): $300M rev, 32% GM, -$10M loss → 8x P/S = $2.4B (-31%)
Bear (20%): $220M rev, 28% GM, -$30M loss → 5x P/S = $1.1B (-69%)

EV = 0.4(0%) + 0.4(-31%) + 0.2(-69%) = -26.2%

At $63, the stock is priced for the bull case. The asymmetry is wrong.

At $40 (near offering floor and options max pain):

Bull (40%): +59%  |  Base (40%): +9%  |  Bear (20%): -50%
EV = +17.2%  |  Forward α ≈ +12% after risk-free

That's where it works.

Options Tell the Same Story

P/C ratio: 0.08 (11.8x calls to puts — extreme retail bullishness). ATM IV: 125%. Max pain: $40 (36.6% below current). The $23 gap between max pain and current price is one of the largest I've seen. Institutional positioning is at $44 (offering price). Retail/momentum is chasing calls at $65+. Unusual activity at $80 calls (3.8x vol/OI). Lock-up expires ~April 6.

Verdict

PASS at $63. Watchlist at $35-45.

The defense transition thesis is correct per primary source data. A&D revenue acceleration, gross margin expansion, OCF inflection, classified programs, cross-ticker corroboration from 7 companies — all confirmed. This is a structural business model transition, not a one-quarter beat.

But +660% 1Y. 13.4x revenue on an unprofitable company. CEO selling into the rally. 7 analysts covering, 6 buys. This is consensus. The alpha was extracted. Forward alpha is negative at current levels.

The system did its job: discovered the thesis, built the worldview (19 evidence items, 3 predictions), assessed timing, and correctly passed. If DOGE/CR noise or lock-up expiry creates a 40-50% pullback to $35-45, the worldview has the evidence ready. Knowledge before capital.

Entry trigger: Material pullback to $35-45 + specific program confirmation 8-K. Kill trigger: Funded backlog drops below $120M, or A&D revenue misses 2 consecutive quarters.